Johnson PharmacareBOM:532154 +2.08%25 Beneish M-Score is 0.00 as of Jul. 05, 2026. GuruFocus rates BOM:532154 with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 86 Diversified Financial Services companies, Johnson Pharmacare ranks worse than 1162789.53% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
The historical rank and industry rank for Johnson Pharmacare's Beneish M-Score or its related term are showing as below:
During the past 13 years, the highest Beneish M-Score of Johnson Pharmacare was -1.43. The lowest was -3.96. And the median was -2.70.
Johnson Pharmacare Beneish M-Score Related Terms
Johnson Pharmacare Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Johnson Pharmacare's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532154 vs XXI, CCXI, DMII: Beneish M-Score Comparison
For the Shell Companies subindustry, Johnson Pharmacare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Pharmacare Beneish M-Score vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Johnson Pharmacare's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Johnson Pharmacare's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Johnson Pharmacare for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 *
+
0.528 *
+
0.404 *
+
0.892 *
+
0.115 *
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 *
+
4.679 *
-
0.327 *
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(0 / (0 + 0))
/
(0 / (0 + 0))
=
/
=
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-557.339 - 0
-
-575.674)
/
220.311
=
0.083223
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Johnson Pharmacare (BOM:532154) has a Beneish M-Score of 0.00 as of Jul. 05, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Johnson Pharmacare and its competitors. According to the industry distribution chart, Johnson Pharmacare ranks #999999 out of 86 companies in the Diversified Financial Services industry.
Is Johnson Pharmacare's Beneish M-Score too high?
Johnson Pharmacare's current Beneish M-Score is 0.00. Based on the distribution chart, Johnson Pharmacare ranks #999999 out of 86 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Johnson Pharmacare has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Johnson Pharmacare's Beneish M-Score compare to XXI and CCXI?
According to the Diversified Financial Services industry distribution chart, Johnson Pharmacare ranks #999999 out of 86 companies for Beneish M-Score. This places Johnson Pharmacare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Diversified Financial Services company?
A good Beneish M-Score depends on the Diversified Financial Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Johnson Pharmacare and its competitors. Johnson Pharmacare's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Pharmacare stock overvalued right now?
Johnson Pharmacare (BOM:532154) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. Johnson Pharmacare's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Johnson Pharmacare (BOM:532154), the current Beneish M-Score is 0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532154 has been successfully added to your 
